CAMBRIDGE, Mass., Oct. 21, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that the United States District Court for the District of Massachusetts today entered an order extending the temporary restraining order enjoining Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd. from offering to sell or selling their generic enoxaparin until October 28, 2011. The Court is continuing to consider Momenta's motion for a preliminary injunction.
